FAM237A, Rather Than Peptide PEN and Procck56‐63, Binds to and Activates the Orphan Receptor GPR83

Hao‐Zheng Li,Yafen Wang,Xiao‐Xia Shao,Yali Liu,Zeng‐Guang Xu,Shilong Wang,Zhan‐Yun Guo
DOI: https://doi.org/10.1111/febs.16765
2023-01-01
FEBS Journal
Abstract:G protein‐coupled receptor 83 (GPR83) is primarily expressed in the brain and is implicated in the regulation of energy metabolism and some anxiety‐related behaviours. Recently, the PCSK1N/proSAAS‐derived peptide PEN, the procholecystokinin‐derived peptide proCCK56‐63, and family with sequence similarity 237 member A (FAM237A) were all reported as efficient agonists of GPR83. However, these results have not yet been reproduced by other laboratories and thus GPR83 is still officially an orphan receptor. The peptide PEN and proCCK56‐63 share sequence similarity; however, they are completely different from FAM237A. To identify its actual ligand(s), in the present study we developed NanoLuc Binary Technology (NanoBiT)‐based ligand‐binding assay, fluorescent ligand‐based visualization, and NanoBiT‐based β‐arrestin recruitment assay for human GPR83. Using these assays, we demonstrated that mature human FAM237A could bind to GPR83 with nanomolar range affinity, and could activate this receptor and induce its internalization with nanomolar range efficiency in transfected human embryonic kidney 293T cells. However, we did not detect any interaction of PEN and proCCK56‐63 with GPR83 using these assays. Thus, our results confirmed that FAM237A is an efficient agonist of GPR83, but did not support PEN and proCCK56‐63 as ligands of this receptor. Clarification of their pairing paves the way for further functional studies of the brain‐specific receptor GPR83 and the so far rarely studied neuropeptide FAM237A in the future.
What problem does this paper attempt to address?